Crackdown on Fake Cancer Drug Syndicate in Delhi

Delhi crime branch arrests four more in connection to counterfeit cancer medication scheme.

The Aryavarth Express
Agency(New Delhi): Delhi’s battle against medical fraud has seen a significant breakthrough with the arrest of four individuals by the city’s crime branch, implicated in a fake cancer drug racket. This latest apprehension increases the tally of those detained in the case to twelve, signaling a robust response to a menacing threat to public health.

The individuals, identified as Rohit, Jitendra, Majid, and Sajid, were apprehended for their roles in the manufacture and distribution of counterfeit cancer treatments. Notably, these accused were employed in the oncology departments of several hospitals within the capital, a factor that potentially facilitated their illicit activities.

Police disclosures reveal the magnitude of the operation, with counterfeit drugs valued at over Rs 25 crore reportedly sold by the syndicate. The culprits, having connected through social media platforms, managed a sophisticated network, underscoring the challenges law enforcement faces in curbing digital-era crimes.

In a concerted effort to dismantle the financial underpinnings of this racket, authorities have frozen 14 bank accounts associated with the accused, cumulatively holding Rs 90 lakh. This action represents a critical step in both penalizing the perpetrators and safeguarding potential victims from harm.

This incident is part of a wider clampdown on illegal pharmaceutical practices in India, as evidenced by a related operation in Telangana. There, the Drugs Control Administration conducted raids leading to the seizure of drugs making unfounded health claims and others priced significantly above government-set limits, highlighting the pervasive challenge of ensuring drug safety and affordability across the nation.

As the investigation continues, further details are anticipated to emerge, shedding light on the extent of this nefarious network and the measures being taken to protect consumers from such dangerous deceit.

Exit mobile version